NO20041802L - Antistoffer mot human vevsfaktor - Google Patents

Antistoffer mot human vevsfaktor

Info

Publication number: NO20041802L
Authority: NO; Norway
Prior art keywords: antibodies; human tissue; tissue factor; factor; human
Prior art date: 2001-10-02

Application number

NO20041802A

Other languages

English (en)

Inventor

Per-Ola Freskgaard

Jes Thorn Clausen

Brit Binow Sorensen

Marianne Kjalke

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-02

Filing date

2004-04-30

Publication date

2004-04-30

2004-04-30 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2004-04-30 Publication of NO20041802L publication Critical patent/NO20041802L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biophysics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20041802A 2001-10-02 2004-04-30 Antistoffer mot human vevsfaktor NO20041802L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200101437		2001-10-02
PCT/DK2002/000644 WO2003029295A1 (en)	2001-10-02	2002-09-30	Human tissue factor antibodies

Publications (1)

Publication Number	Publication Date
NO20041802L true NO20041802L (no)	2004-04-30

Family

ID=8160743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041802A NO20041802L (no)	2001-10-02	2004-04-30	Antistoffer mot human vevsfaktor

Country Status (15)

Country	Link
EP (1)	EP1434802A1 (no)
JP (1)	JP2005512970A (no)
KR (1)	KR20040045478A (no)
CN (1)	CN1575302A (no)
BR (1)	BR0213046A (no)
CA (1)	CA2460917A1 (no)
CZ (1)	CZ2004454A3 (no)
HU (1)	HUP0401658A2 (no)
IL (1)	IL160998A0 (no)
MX (1)	MXPA04003051A (no)
NO (1)	NO20041802L (no)
PL (1)	PL368989A1 (no)
RU (1)	RU2004113373A (no)
WO (1)	WO2003029295A1 (no)
ZA (1)	ZA200402303B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030109680A1 (en)	2001-11-21	2003-06-12	Sunol Molecular Corporation	Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en)	1997-03-10	2006-10-19	Jin-An Jiao	Use of anti-tissue factor antibodies for treating thromboses
US5986065A (en)	1997-03-10	1999-11-16	Sunol Molecular Corporation	Antibodies for inhibiting blood coagulation and methods of use thereof
US7749498B2 (en)	1997-03-10	2010-07-06	Genentech, Inc.	Antibodies for inhibiting blood coagulation and methods of use thereof
EP1374896A4 (en) *	2001-03-26	2005-04-06	Koji Suzuki	MEANS TO IMPROVE THE FLUID CHARACTERISTICS OF BLOOD
AU2003277832A1 (en) *	2002-10-31	2004-05-25	Novo Nordisk A/S	Humanized tissue factor antibodies
WO2004064870A2 (en) *	2003-01-22	2004-08-05	Novo Nordisk A/S	Radiolabelled tissue factor binding agent and the use thereof
US9708410B2 (en)	2003-05-30	2017-07-18	Janssen Biotech, Inc.	Anti-tissue factor antibodies and compositions
US20050031615A1 (en) *	2003-05-30	2005-02-10	Anderson G. Mark	Method of inhibiting tumor growth with anti-tissue factor antibodies
US7605235B2 (en)	2003-05-30	2009-10-20	Centocor, Inc.	Anti-tissue factor antibodies and compositions
MXPA05013789A (es) *	2003-06-19	2006-06-27	Tanox Inc	Composiciones y metodos para tratar los desordenes relacionados con la coagulacion.
EP1667718A4 (en) *	2003-08-29	2007-05-02	Centocor Inc	METHOD FOR STIMULATING THE SURVIVAL OF A GRAFT WITH ANTI-TISSUE FACTOR ANTIBODY
EP1744734A2 (en) *	2004-02-20	2007-01-24	Novo Nordisk A/S	Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds
KR101544108B1 (ko)	2006-09-08	2015-08-13	애브비 바하마스 리미티드	인터루킨-13 결합 단백질
CN101423552B (zh) *	2008-02-29	2012-05-16	复旦大学	一种人源抗人组织因子Fab及其制备方法
AU2016277670B2 (en) *	2008-12-09	2019-02-07	Genmab A/S	Human antibodies against tissue factor
UA109633C2 (uk)	2008-12-09	2015-09-25		Антитіло людини проти тканинного фактора
AU2013203150B2 (en) *	2008-12-09	2016-09-22	Genmab A/S	Human antibodies against tissue factor
WO2010131235A1 (en) *	2009-05-15	2010-11-18	University Of The Free State	Inhibitory antibody fragments to human tissue factor
HRP20171789T1 (hr)	2010-06-15	2017-12-29	Genmab A/S	Konjugati humanog protutijela s lijekom protiv tkivnog faktora
US8722044B2 (en)	2011-03-15	2014-05-13	Janssen Biotech, Inc.	Human tissue factor antibody and uses thereof
WO2017028823A1 (zh) *	2015-08-20	2017-02-23	复旦大学	靶向于组织因子的抗体、其制备方法和用途
CN106938051B (zh)	2016-08-22	2019-10-11	复旦大学	靶向于组织因子的抗体-药物偶联物
EP3502141A4 (en) *	2016-08-22	2020-04-08	Fudan University	ANTIBODIES TAKEN AGAINST THE TISSUE FACTOR, MANUFACTURING METHODS THEREFOR AND USE THEREOF
TWI841554B (zh)	2018-03-21	2024-05-11	丹麥商珍美寶股份有限公司	以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法
BR112020022642A2 (pt)	2018-05-07	2021-02-17	Genmab A/S	método para tratar câncer em um indivíduo, e, estojo
TWI844571B (zh)	2018-10-30	2024-06-11	丹麥商珍美寶股份有限公司	使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223427A (en) *	1987-03-31	1993-06-29	The Scripps Research Institute	Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
US6001978A (en) *	1987-03-31	1999-12-14	The Scripps Research Institute	Human tissue factor related DNA segments polypeptides and antibodies
JP2779193B2 (ja) *	1989-02-02	1998-07-23	帝人株式会社	抗ヒト組織因子モノクローナル抗体
AU716282B2 (en) *	1995-06-07	2000-02-24	Johnson & Johnson Research Pty. Limited	CDR-grafted anti-tissue factor antibodies and methods of use thereof
EP2363484A3 (en) *	1998-04-03	2012-04-25	Chugai Seiyaku Kabushiki Kaisha	Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
BR0014667A (pt) *	1999-10-01	2002-07-02	Chugai Pharmaceutical Co Ltd	Prevenção e tratamento de doenças relacionadas à coagulação sanguìnea
WO2001070984A2 (en) *	2000-03-16	2001-09-27	Genentech, Inc.	Anti-tissue factor antibodies with enhanced anticoagulant potency

2002
- 2002-09-30 MX MXPA04003051A patent/MXPA04003051A/es unknown
- 2002-09-30 KR KR10-2004-7004942A patent/KR20040045478A/ko not_active Withdrawn
- 2002-09-30 BR BR0213046-7A patent/BR0213046A/pt not_active IP Right Cessation
- 2002-09-30 JP JP2003532540A patent/JP2005512970A/ja not_active Withdrawn
- 2002-09-30 CN CNA028208463A patent/CN1575302A/zh active Pending
- 2002-09-30 CA CA002460917A patent/CA2460917A1/en not_active Abandoned
- 2002-09-30 HU HU0401658A patent/HUP0401658A2/hu unknown
- 2002-09-30 EP EP02800043A patent/EP1434802A1/en not_active Withdrawn
- 2002-09-30 CZ CZ2004454A patent/CZ2004454A3/cs unknown
- 2002-09-30 RU RU2004113373/13A patent/RU2004113373A/ru not_active Application Discontinuation
- 2002-09-30 IL IL16099802A patent/IL160998A0/xx unknown
- 2002-09-30 PL PL02368989A patent/PL368989A1/xx not_active Application Discontinuation
- 2002-09-30 WO PCT/DK2002/000644 patent/WO2003029295A1/en not_active Ceased
2004
- 2004-03-24 ZA ZA200402303A patent/ZA200402303B/en unknown
- 2004-04-30 NO NO20041802A patent/NO20041802L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200402303B (en)	2004-11-25
JP2005512970A (ja)	2005-05-12
WO2003029295A1 (en)	2003-04-10
KR20040045478A (ko)	2004-06-01
RU2004113373A (ru)	2005-03-27
IL160998A0 (en)	2004-08-31
EP1434802A1 (en)	2004-07-07
CA2460917A1 (en)	2003-04-10
MXPA04003051A (es)	2004-07-05
PL368989A1 (en)	2005-04-04
CN1575302A (zh)	2005-02-02
CZ2004454A3 (cs)	2004-09-15
HUP0401658A2 (hu)	2004-11-29
BR0213046A (pt)	2005-06-28

Publication	Publication Date	Title
NO20041802L (no)	2004-04-30	Antistoffer mot human vevsfaktor
NO20023266D0 (no)	2002-07-05	Antistoffer mot humant IL-1
NO20026063L (no)	2003-02-27	Antistoffer mot human MCP-1
NO20004133D0 (no)	2000-08-18	Antistoffer mot human CD40
DK1313769T3 (da)	2008-09-15	Antistoffer mod humant IL-1beta
NO20042388L (no)	2004-08-09	Antistoff mot CD40
NO20034554D0 (no)	2003-10-10	Antistoffer mot VLA-1
NO20041018L (no)	2004-03-10	Antistoffer mot OPGL
IS6779A (is)	2003-04-11	Mannlíkt mótefni gegn LT-beta-R
IS8266A (is)	2006-01-26	Breytt mennsk IGF-1R mótefni
EP1506286A4 (en)	2008-05-28	NEUTRALIZATION OF A HUMAN ANTI-IGFR ANTIBODY
ATE549033T1 (de)	2012-03-15	Therapeutischer menschlicher monoklonaler anti-il-1r1-antikörper
DE60118511D1 (de)	2006-05-18	Blutsammelsatz
NO20054170D0 (no)	2005-09-07	Antistoff mot human IL-21 reseptor og anvendelser derav
DE60324178D1 (de)	2008-11-27	THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN
IS7499A (is)	2004-10-11	Mennsk mótefni gegn beta-amýloíðpeptíðum
DE60221143D1 (de)	2007-08-23	Brusteinlage enthaltend hautpflegemittel
NO20031129L (no)	2003-05-12	Human koagulasjonsfaktor VII-varianter
DE60205514D1 (de)	2005-09-22	Wegwerfwindel
DE60211241D1 (de)	2006-06-14	Zusammengesetzte Damenbinde
ATE357459T1 (de)	2007-04-15	Antikörper gegen mensliches il-12
DE60112705D1 (de)	2005-09-22	Blutsammelsatz
ATE258035T1 (de)	2004-02-15	Wegwerfartikel für menschliche fäkalien
EP1646401A4 (en)	2007-07-18	SPECIFIC HUMAN ANTIBODIES
AR028262A1 (es)	2003-04-30	Anticuerpos especificos de fap-alfa humanos

Legal Events

Date	Code	Title	Description
2008-04-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application